Market Size of Asia-Pacific Arachidonic Acid Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 7.40 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Asia-Pacific Arachidonic Acid Market Analysis
Asia-Pacific Arachidonic acid market is projected to grow at a CAGR of 7.4% during the forecast period (2020- 2025).
- The major driver for the arachidonic acidmarket, is the high birth rate in countries, like India and China, which has increased its application in infant formula products, sports nutrition, and dietary supplement products, and increased in fortification of products to meet the nutritional gap.
- Also, the increase in the number of road accidents and the growing number of cases of muscle damage are expected to boost the demand. The increasing levels of childcare awareness, baby care products, and use of ARA as sports supplements serve as the primary growth drivers for ARA market.
Asia-Pacific Arachidonic Acid Industry Segmentation
The arachidonic acid market is segmented by technology used which includes solvent extraction and solid-phase extraction. In the application type, the arachidonic acid market is segmented into food and beverage and pharmaceutical. The food and beverage segment is further divided into infant formula and dietary supplements. The study also involves the analysis of regions such as India, China, Australia, Japan and rest of Asia-Pacific.
By Technology | |
Solvent Extraction | |
Solid-Phase Extraction |
By Application | ||||
| ||||
Pharmaceuticals |
Geography | |||||||
|
Asia-Pacific Arachidonic Acid Market Size Summary
The Asia-Pacific arachidonic acid market is experiencing significant growth, driven by factors such as high birth rates in countries like India and China, which have increased the application of arachidonic acid in infant formula products, sports nutrition, and dietary supplements. The market is also benefiting from the rising awareness of childcare and baby care products, as well as the use of arachidonic acid as a sports supplement. The demand is further bolstered by the increasing incidence of road accidents and muscle damage cases, which necessitate the use of dietary supplements for recovery and nutrition.
The infant formula segment dominates the market, with China leading the region due to its substantial share in the global infant formula market. The country's demand for high-quality imported infant formula products contributes significantly to its arachidonic acid consumption. Other countries like India, Australia, Singapore, Malaysia, and Thailand are also witnessing growth, supported by consumer awareness and developed economies. The market is fragmented, with key players such as DSM, Cargill, and Cabio Bioengineering investing in new product development and marketing strategies to maintain their competitive edge amidst commodity cost volatility.
Asia-Pacific Arachidonic Acid Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Drivers
-
1.2 Market Restraints
-
1.3 Porter's Five Forces Analysis
-
1.3.1 Threat of New Entrants
-
1.3.2 Bargaining Power of Buyers/Consumers
-
1.3.3 Bargaining Power of Suppliers
-
1.3.4 Threat of Substitute Products
-
1.3.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Technology
-
2.1.1 Solvent Extraction
-
2.1.2 Solid-Phase Extraction
-
-
2.2 By Application
-
2.2.1 Food and Beverage
-
2.2.1.1 Infant Formula
-
2.2.1.2 Dietary Supplements
-
-
2.2.2 Pharmaceuticals
-
-
2.3 Geography
-
2.3.1 Asia-Pacific
-
2.3.1.1 India
-
2.3.1.2 China
-
2.3.1.3 Australia
-
2.3.1.4 Japan
-
2.3.1.5 Rest of Asia-Pacific
-
-
-
Asia-Pacific Arachidonic Acid Market Size FAQs
What is the current Asia-Pacific Arachidonic Acid Market size?
The Asia-Pacific Arachidonic Acid Market is projected to register a CAGR of 7.40% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Arachidonic Acid Market?
Cargill Inc., CABIO Biotech Wuhan Co Ltd, Cayman Chemical, Guangdong Runke Bioengineering Co., Ltd. and Royal DSM are the major companies operating in the Asia-Pacific Arachidonic Acid Market.